6-Acetyl-8-cyclopentyl-5-methyl-2-(5-(piperazin-1-yl)pyridin-2-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride
98%
- Product Code: 110624
CAS:
827022-32-2
| Molecular Weight: | 483.99 g./mol | Molecular Formula: | C₂₄H₂₉N₇O₂HCl |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and drug development. It serves as a potent and selective inhibitor of cyclin-dependent kinases (CDKs), which are crucial regulators of cell cycle progression. By targeting specific CDKs, it has potential applications in cancer therapy, particularly in halting the proliferation of cancer cells. Its mechanism involves inducing cell cycle arrest and promoting apoptosis in malignant cells, making it a candidate for treating various cancers, including breast, lung, and leukemia. Additionally, its structural features allow for further optimization and modification to enhance efficacy and reduce off-target effects, contributing to its role in preclinical research and the development of novel anticancer agents.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Beige Powder |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿590.00 |
+
-
|
| 0.010 | 10-20 days | ฿990.00 |
+
-
|
| 0.050 | 10-20 days | ฿2,840.00 |
+
-
|
| 0.100 | 10-20 days | ฿4,820.00 |
+
-
|
| 0.250 | 10-20 days | ฿7,362.00 |
+
-
|
| 1.000 | 10-20 days | ฿12,510.00 |
+
-
|
| 5.000 | 10-20 days | ฿39,420.00 |
+
-
|
6-Acetyl-8-cyclopentyl-5-methyl-2-(5-(piperazin-1-yl)pyridin-2-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride
This compound is primarily utilized in the field of medicinal chemistry and drug development. It serves as a potent and selective inhibitor of cyclin-dependent kinases (CDKs), which are crucial regulators of cell cycle progression. By targeting specific CDKs, it has potential applications in cancer therapy, particularly in halting the proliferation of cancer cells. Its mechanism involves inducing cell cycle arrest and promoting apoptosis in malignant cells, making it a candidate for treating various cancers, including breast, lung, and leukemia. Additionally, its structural features allow for further optimization and modification to enhance efficacy and reduce off-target effects, contributing to its role in preclinical research and the development of novel anticancer agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :